Jump to: [Chinese Items]   [0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] or enter the first few letters:

Showing items 1001-1025 of 12972. (519 Page(s) Totally) << < 36 37 38 39 40 41 42 43 44 45 > >> View [10|25|50] records per page

Date	Title	Relation
2007-08-01	Arsenic and diabetes and hypertension in human populations: A review	Toxicology and Applied Pharmacology. 2007 Aug;222(3):298-304.
2010-05-17	Arsenic and metabolic syndrome	The 3rd International Congress on Arsenic in the Environment, 2010. 2010 May 17-21:254-256.
2011-01	Arsenic and type 2 diabetes and hypertension in human populations	Health Hazards of Arsenic Poisoning Environmental: From Epidemic to Pandemic. 2011 Jan;Chapter 9:135-160.
2006-09	Arsenic carcinogenesis in the skin	Journal of Biomedical Science. 2006 Sep;13(5):657-666.
2005-09	Arsenic dose and its relation to cardiovascular risk among residents in middle Taiwan	Epidemiology. 2005 Sep;16(5):S25.
2012-07	Arsenic exposure in pregnancy increases the risk of adverse birth outcomes of newborn in Taiwan	Understanding the Geological and Medical Interface of Arsenic- As 2012: Proceedings of the 4th International Congress on Arsenic in the Environment, 22-27 July 2012, Cairns, Australia. 2012 Jul:157-158.
2005-08-15	Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan	Toxicology and Applied Pharmacology. 2005 Aug;206(3):299-308.
2006-03-01	Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan [Erratum:Toxicology and Applied Pharmacology. 2005 Aug;206(3):299-308.]	Toxicology and Applied Pharmacology. 2006 Mar;211(2):175.
2004-01	Arsenic induces human keratinocyte apoptosis by the FAS/FAS ligand pathway, which correlates with alterations in nuclear factor-kappa B and activator protein-1 activity	Journal of Investigative Dermatology. 2004 Jan;122(1):125-129.
2005-08	Arsenic ingestion and increased microvascular disease risk: observations from the southwestern arseniasis-endemic area in Taiwan	International Journal of Epidemiology. 2005 Aug;34(4):936-943.
2006-09-21	Arsenic inhibits induction of cytochrome P450 1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatoma cells	Journal of Hazardous Materials. 2006 Sep;137(2):716-722.
2012-07	Arsenic metabolism, lactate dehydrogenase and electrocardiogram abnormality among residents in the arseniasis-endemic areas of southwestern Taiwan	Understanding the Geological and Medical Interface of Arsenic- As 2012: Proceedings of the 4th International Congress on Arsenic in the Environment, 22-27 July 2012, Cairns, Australia. 2012 Jul:155-156.
2012-07	Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan	Chemosphere. 2012 Jul;88(4):432-438.
2007-01	Arsenic methylation, urinary arsenic metabolites and human diseases: Current perspective	Journal of Environmental Science and Health Part C-Environmental Carcinogenesis & Ecotoxicology Reviews. 2007 Jan;25(1):1-22.
2007-12-01	Arsenic promotes centrosome abnormalities and cell colony formation in p53 compromised human lung cells	Toxicology and Applied Pharmacology. 2007 Dec;225(2):162-170.
2014-12	Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-kappaB signaling in cervical cancer	Annals of Surgical Oncology. 2014 Dec;21(4 Suppl.):687-695.
2018-07	Arsenic, DNA damage, and cancers of bladder and kidney - a long-term follow-up of residents in arseniasis endemic area of north-eastern Taiwan	Environmental Arsenic in a Changing World. 2018 Jul:317-318.
2009-08	Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells	Toxicology in Vitro. 2009 Aug;23(5):897-905.
2005-11	Arsenite enhances tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1	Toxicology and Applied Pharmacology. 2005 Nov;209(1):10-18.
2005-11-01	Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase	Toxicology and Applied Pharmacology. 2005 Nov;208(3):277-284.
2010-02-15	Arsenite promotes centrosome abnormalities under a p53 compromised status induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)	Toxicology and Applied Pharmacology. 2010 Feb 15;243(1):55-62.
2016-03-22	Arsenite regulates prolongation of glycan residues of membrane glycoprotein: A pivotal study via wax physisorption kinetics and FTIR imaging	International Journal of Molecular Sciences. 2016 Mar 22;17(3):Article number 427.
2018-05-14	Arthroprotective effects of Cf-02 sharing structural similarity with quercetin	International Journal of Molecular Sciences. 2018 May 14;19(5):Article number 1453.
2020-08	Artificial intelligence approach fighting COVID-19 with repurposing drugs	Biomedical Journal. 2020 Aug;43(4):355-362.
2021-09-15	Artificial intelligence-assisted identification of genetic factors predisposing high-risk individuals to asymptomatic heart failure	Cells. 2021 Sep 15;10(9):Article number 2430.

Showing items 1001-1025 of 12972. (519 Page(s) Totally) << < 36 37 38 39 40 41 42 43 44 45 > >> View [10|25|50] records per page